FDA clears Smiths Medical's wireless infusion pump

Smiths Medical can now bring wireless infusion pumps to U.S. hospitals. The FDA granted 510(k) clearance to the firm's Medfusion 4000 wireless syringe infusion pump with PharmGuard management software, the company said in a release. The system enables clinicians to wirelessly send and receive details on meds that are pumped into patients.

The system is designed to increase efficiency, and a key benefit for patients is the reduction in medication errors, which can make them sicker and prolong their costly hospital stays. The software keeps clinicians informed of medication guidelines while they set doses for the infusion system, and it can track data from multiple pumps to provide data on adherence to quality standards.

Medfusion 4000 is an updated version of Smiths Medical's Medfusion 3500 infusion pump system. Prior to getting the FDA's nod for the updated version, the St. Paul, MN-based firm had been selling the wireless version in Canada and other ex-U.S. markets. Smiths Medical is the medication delivery and medical products unit of the London-based Smiths Group.

- here's the release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.